Atelerix granted government funding to help fight COVID-19

26th May 2020

Extending the shelf life of COVID-19 test kits Testing for COVID-19 in the UK, and indeed globally, is a huge task and more testing will be needed to both monitor and control the spread of the disease.  However, a severe...

Atelerix Raises Further Funding of £600,000

14th May 2020

Atelerix raises further funding to develop cell and gene therapy applications.  14th May 2020 — Cambridge and Newcastle, UK – Atelerix, inventors and owners of the innovative cell encapsulation technology, incorporated within the widely used the “Ready” product range, today...

Increasing the accessibility of cell-based therapies

4th May 2020

A case study following the adoption of BeadReady™ for the room temperature shipment of cell therapies in India by Steve Swioklo, Senior Scientist and Co-founder It was the 20th April 2017 when I first visited Hyderabad, to attend a workshop...

Sanj Kumar joins Atelerix as Chief Business Officer

18th November 2019

November 18th 2019 — Cambridge and Newcastle, UK – Atelerix, pioneers in the storage and transport of cells at room temperature, announced today that it has significantly expanded and strengthened the commercialisation of its innovative product range by hiring industry...

Atelerix Consortium Awarded £267,000 Innovate UK Grant

21st August 2019

Cambridge and Newcastle, UK, 21st August 2019: Atelerix, pioneers in the storage and transport of cells at room temperature, today announces that it has been awarded a grant of £267,000 from Innovate UK, the UK’s innovation agency, with collaborators Rexgenero...

Atelerix Raises Follow-on Funding Round of £700,000

9th May 2019

9th May 2019 — Cambridge and Newcastle, UK – Atelerix, creators of an innovative cell encapsulation technology, today announces it has closed a second round of funding of £700,000 to accelerate development of its cell transport products to market. Atelerix’s...